One of the most researched tripeptide ingredients for cardiovascular health, VasoDrive-AP (also known as AmealPeptide®) is said to improve arterial flexibility by increasing the production of endothelial nitric oxide synthase (eNOS).*
Derived from milk protein through a proprietary enzymatic process, VasoDrive-AP occurs in very small amounts in casein as tripeptides, which are three specific amino acids joined together in a precise configuration.
It works to support arterial elasticity by inhibiting an enzyme that leads to the constriction of blood vessels.*
The two tripeptides in VasoDrive-AP are known as the lactotripeptides Valyl-Prolyl-Proline (VPP) and Isoleucyl- Prolyl-Proline (IPP); they are derived from the amino acids valine, proline, and isoleucine.
It is manufactured by enzymatically hydrolyzing casein in a precise manner with the protease derived from Aspergillus oryzae in such a way that the peptides are not damaged or broken down into their individual amino acids. They are also not degraded in the human digestive system because of their precise configuration and can be absorbed intact to be physiologically active.
These lactotripeptide combinations are not found in high enough quantities in common foods (such as dairy) to be sufficiently healthful.
Supported by more than 30 published studies — including over a dozen double-blind, placebo-controlled human clinical trials — VasoDrive-AP (Amealpeptide) promotes arterial elasticity.*
VasoDrive-AP also boosts exercise performance by improving recovery and sustaining endothelial function throughout training cycles.*
Research shows that VasoDrive-AP supplementation can:*
VasoDrive-AP can be used in beverages as well as in dietary Supplements.
)
VasoDrive-AP works by inhibiting an enzyme that leads to the constriction of blood vessels.* This vasodilating action is believed to be at least partly responsible for VasoDrive-AP’s clinically documented effect on cardiovascular health.*
)
In multiple human studies, VasoDrive-AP (AmealPeptide) exerted an effect in 3-4
weeks, safely and with no side effects.* AmealPeptide is FDA GRAS for inclusion
in food, beverages and dietary supplements in the US and is FOSHU-certified by
the Consumer Affairs Agency, Government of Japan.
While it is made from milk protein, the lactose levels in VasoDrive-AP (AmealPeptide)
are undetectable (under .05%), so it is considered safe for those with lactose intolerance.*
